ArticleMolecular cancer therapeutics2011

Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer.

Holly Symolon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.